Identification of Map4k4 as a Novel Suppressor of Skeletal Muscle Differentiation

REFERENCES

• Braun T, Gautel M. 2011. Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat. Rev. Mol. Cell Biol. 12:349–361.
   PubMed Web of Science ®Google Scholar
• Molkentin JD, Black BL, Martin JF, Olson EN. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125–1136.
   PubMedGoogle Scholar
• Olson EN, Klein WH. 1994. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1–8.
   PubMed Web of Science ®Google Scholar
• Berkes CA, Tapscott SJ. 2005. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 16:585–595.
   PubMed Web of Science ®Google Scholar
• Hinterberger TJ, Sassoon DA, Rhodes SJ, Konieczny SF. 1991. Expression of the muscle regulatory factor MRF4 during somite and skeletal myofiber development. Dev. Biol. 147:144–156.
   PubMedGoogle Scholar
• Kassar-Duchossoy L, Gayraud-Morel B, Gomes D, Rocancourt D, Buckingham M, Shinin V, Tajbakhsh S. 2004. Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. Nature 431:466–471.
   PubMed Web of Science ®Google Scholar
• Suelves M, Lluis F, Ruiz V, Nebreda AR, Munoz-Canoves P. 2004. Phosphorylation of MRF4 transactivation domain by p38 mediates repression of specific myogenic genes. EMBO J. 23:365–375.
   PubMed Web of Science ®Google Scholar
• Sumariwalla VM, Klein WH. 2001. Similar myogenic functions for myogenin and MRF4 but not MyoD in differentiated murine embryonic stem cells. Genesis 30:239–249.
   PubMedGoogle Scholar
• Zhang W, Liu HT. 2002. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 12:9–18.
   PubMed Web of Science ®Google Scholar
• Aouadi M, Bost F, Caron L, Laurent K, Le Marchand Brustel Y, Binetruy B. 2006. p38 mitogen-activated protein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis. Stem Cells 24:1399–1406.
   PubMed Web of Science ®Google Scholar
• Aouadi M, Laurent K, Prot M, Le Marchand-Brustel Y, Binetruy B, Bost F. 2006. Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55:281–289.
   PubMedGoogle Scholar
• Bost F, Aouadi M, Caron L, Even P, Belmonte N, Prot M, Dani C, Hofman P, Pages G, Pouyssegur J, Le Marchand-Brustel Y, Binetruy B. 2005. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54:402–411.
   PubMed Web of Science ®Google Scholar
• Wada T, Penninger JM. 2004. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23:2838–2849.
   PubMed Web of Science ®Google Scholar
• Johnson GL, Lapadat R. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911–1912.
   PubMed Web of Science ®Google Scholar
• Knight JD, Kothary R. 2011. The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis. Skelet. Muscle 1:29.
   PubMedGoogle Scholar
• Lluis F, Perdiguero E, Nebreda AR, Munoz-Canoves P. 2006. Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol. 16:36–44.
   PubMed Web of Science ®Google Scholar
• Dan I, Watanabe NM, Kusumi A. 2001. The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol. 11:220–230.
   PubMed Web of Science ®Google Scholar
• Collins CS, Hong J, Sapinoso L, Zhou Y, Liu Z, Micklash K, Schultz PG, Hampton GM. 2006. A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase. Proc. Natl. Acad. Sci. U. S. A. 103:3775–3780.
   PubMed Web of Science ®Google Scholar
• Liu AW, Cai J, Zhao XL, Jiang TH, He TF, Fu HQ, Zhu MH, Zhang SH. 2011. shRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth. Clin. Cancer Res. 17:710–720.
   PubMed Web of Science ®Google Scholar
• Xue Y, Wang X, Li Z, Gotoh N, Chapman D, Skolnik EY. 2001. Mesodermal patterning defect in mice lacking the Ste20 NCK interacting kinase (NIK). Development 128:1559–1572.
   PubMed Web of Science ®Google Scholar
• Zohn IE, Li Y, Skolnik EY, Anderson KV, Han J, Niswander L. 2006. p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell 125:957–969.
   PubMed Web of Science ®Google Scholar
• Tang X, Guilherme A, Chakladar A, Powelka AM, Konda S, Virbasius JV, Nicoloro SM, Straubhaar J, Czech MP. 2006. An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARgamma, adipogenesis, and insulin-responsive hexose transport. Proc. Natl. Acad. Sci. U. S. A. 103:2087–2092.
   PubMed Web of Science ®Google Scholar
• Guntur KV, Guilherme A, Xue L, Chawla A, Czech MP. 2010. Map4k4 negatively regulates peroxisome proliferator-activated receptor (PPAR) gamma protein translation by suppressing the mammalian target of rapamycin (mTOR) signaling pathway in cultured adipocytes. J. Biol. Chem. 285:6595–6603.
   PubMedGoogle Scholar
• Bouzakri K, Zierath JR. 2007. MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance. J. Biol. Chem. 282:7783–7789.
   PubMed Web of Science ®Google Scholar
• Tesz GJ, Aouadi M, Prot M, Nicoloro SM, Boutet E, Amano SU, Goller A, Wang M, Guo CA, Salomon WE, Virbasius JV, Baum RA, O'Connor MJJr, Soto E, Ostroff GR, Czech MP. 2011. Glucan particles for selective delivery of siRNA to phagocytic cells in mice. Biochem. J. 436:351–362.
   PubMedGoogle Scholar
• Pasut A, Oleynik P, Rudnicki MA. 2012. Isolation of muscle stem cells by fluorescence activated cell sorting cytometry. Methods Mol. Biol. 798:53–64.
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–408.
   PubMed Web of Science ®Google Scholar
• Gros J, Manceau M, Thome V, Marcelle C. 2005. A common somitic origin for embryonic muscle progenitors and satellite cells. Nature 435:954–958.
   PubMed Web of Science ®Google Scholar
• Nishiyama T, Kii I, Kudo A. 2004. Inactivation of Rho/ROCK signaling is crucial for the nuclear accumulation of FKHR and myoblast fusion. J. Biol. Chem. 279:47311–47319.
   PubMed Web of Science ®Google Scholar
• Baumgartner M, Sillman AL, Blackwood EM, Srivastava J, Madson N, Schilling JW, Wright JH, Barber DL. 2006. The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors. Proc. Natl. Acad. Sci. U. S. A. 103:13391–13396.
   PubMed Web of Science ®Google Scholar
• Cuenda A, Cohen P. 1999. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 274:4341–4346.
   PubMed Web of Science ®Google Scholar
• Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, Karin M, Wang JY, Puri PL. 2000. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell. Biol. 20:3951–3964.
   PubMed Web of Science ®Google Scholar
• Zetser A, Gredinger E, Bengal E. 1999. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 274:5193–5200.
   PubMed Web of Science ®Google Scholar
• Khurana A, Dey CS. 2004. Involvement of c-Jun N-terminal kinase activities in skeletal muscle differentiation. J. Muscle Res. Cell Motil. 25:645–655.
   PubMedGoogle Scholar
• Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, Soto E, Ostroff GR, Czech MP. 2009. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 458:1180–1184.
   PubMed Web of Science ®Google Scholar
• Rajan S, Chu Pham Dang H, Djambazian H, Zuzan H, Fedyshyn Y, Ketela T, Moffat J, Hudson TJ, Sladek R. 2012. Analysis of early C2C12 myogenesis identifies stably and differentially expressed transcriptional regulators whose knock-down inhibits myoblast differentiation. Physiol. Genomics 44:183–197.
   PubMed Web of Science ®Google Scholar
• Hay N, Sonenberg N. 2004. Upstream and downstream of mTOR. Genes Dev. 18:1926–1945.
   PubMed Web of Science ®Google Scholar
• Winter B, Kautzner I, Issinger OG, Arnold HH. 1997. Two putative protein kinase CK2 phosphorylation sites are important for Myf-5 activity. Biol. Chem. 378:1445–1456.
   PubMedGoogle Scholar
• Alter J, Rozentzweig D, Bengal E. 2008. Inhibition of myoblast differentiation by tumor necrosis factor alpha is mediated by c-Jun N-terminal kinase 1 and leukemia inhibitory factor. J. Biol. Chem. 283:23224–23234.
   PubMedGoogle Scholar
• Chen SE, Jin B, Li YP. 2007. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am. J. Physiol. Cell Physiol. 292:C1660–C1671.
   PubMed Web of Science ®Google Scholar
• Coletti D, Yang E, Marazzi G, Sassoon D. 2002. TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. EMBO J. 21:631–642.
   PubMed Web of Science ®Google Scholar
• Charge SB, Rudnicki MA. 2004. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84:209–238.
   PubMed Web of Science ®Google Scholar
• Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G. 2010. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J. Clin. Invest. 120:11–19.
   PubMed Web of Science ®Google Scholar
• Cooper RN, Tajbakhsh S, Mouly V, Cossu G, Buckingham M, Butler-Browne GS. 1999. In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J. Cell Sci. 112:2895–2901.
   PubMed Web of Science ®Google Scholar
• Gayraud-Morel B, Chretien F, Flamant P, Gomes D, Zammit PS, Tajbakhsh S. 2007. A role for the myogenic determination gene Myf5 in adult regenerative myogenesis. Dev. Biol. 312:13–28.
   PubMed Web of Science ®Google Scholar